PRELUDE CAPITAL MANAGEMENT, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 82 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$13,000
-7.1%
3,869
+93.4%
0.00%
-100.0%
Q2 2016$14,0002,0000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 1,510,872$800,7620.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 122,892$65,1330.01%
Bernardo Wealth Planning LLC 38,578$20,4460.01%
Key FInancial Inc 7,500$5,4900.00%
Penserra Capital Management LLC 215,722$1140.00%
King Wealth Management Group 16,000$80.00%
Newbridge Financial Services Group, Inc. 6,075$3,2200.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 115,900$61,4270.00%
ZEKE CAPITAL ADVISORS, LLC 49,700$26,3410.00%
Founders Capital Management 2,000$10.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders